This messaging framework was developed to support advocates as they raise awareness and build support for multipurpose prevention technologies (MPTs) for reproductive health in India. The framework provides a menu of messaging options that advocates can use in presentations, brochures, websites, speeches, or other outreach efforts to help advance support for MPTs in India. It is designed as a trifold brochure.

Publication date: December 2012

Region: Asia

The Caucus on New and Underused Reproductive Health Technologies is a community of practice established under the auspices of the Reproductive Health Supplies Coalition, for which PATH serves as Secretariat. Caucus members developed this series of peer-reviewed briefs on underused reproductive health technologies. Responsibility for the selection and contents of the briefs rests solely with the Caucus and does not imply endorsement of any single technology by the Coalition or its wider membership. The briefs are available in one combined file as well as separately. For more information on the Caucus, please visit http://rhsupplies.org/index.php?id=894 or contact secretariat@rhsupplies.org.

Publication date: May 2012

Region: Global

Since 2003, PATH has conducted a wide range of activities to inform and advance the development of novel microbicide-delivery methods that are safe, acceptable, affordable, and appropriate for use in low-resource settings. This fact sheet describes how PATH identified a paper, user-filled applicator as an important, practical option that could help reduce cost per dose, thereby improving access to microbicide products in impoverished regions most affected by HIV.

Publication date: June 2012

Region: Global

This brochure outlines PATH's work to help Kenya's health care sector improve services and strengthen community networks while empowering Kenyans to adopt healthier lifestyles. PATH offers novel approaches and technical expertise to address a range of health challenges, and we manage projects that reach millions of Kenyans.

Publication date: November 2011

Region: Africa

This brochure outlines PATH's work to improve health in South Africa by bringing effective interventions to the people who need them most. Our interventions make birth safer, enhance infant and young child health, combat HIV/AIDS, strengthen health systems, and support improved sanitation.

Publication date: October 2011

Region: Africa

This document provides historical information on the PATH-designed Woman's Condom, which could help couples around the world reduce their risk of HIV, other sexually transmitted infections, and unintended pregnancy.

Publication date: 2005

Region: Global

This fact sheet summarizes the performance objectives, key features, and product specifications of the PATH Woman's Condom.

Author: Robertson J

Publication date: September 2005

Region: Global

This website about PATH’s Reproductive Health global program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2013

Region: Global

Part of series: PATH's program websites

The Reproductive Health Supplies Coalition is a global partnership of public, private, and nongovernmental organizations dedicated to ensuring that all people in low- and middle-income countries can access and use affordable, high-quality supplies to ensure their better reproductive health.

Publication date: 2013

Region: Global

Part of series: Websites

On October 23–24, 2003, the Global Campaign for Microbicides brought together 64 people from 12 countries to rethink the issues and ethical dilemmas facing the field of microbicide development. The consultation comprised a broad range of stakeholders, including advocates, ethicists, clinical investigators, community members, drug regulatory authorities, and past participants in microbicide clinical trials. The report is available as one large file and as multiple smaller files for easier downloading.

Publication date: March 2005

Region: Global

This publication describes the public health potential of multipurpose prevention technologies -- that is, technologies that prevent unintended pregnancy; sexually transmitted infections, including HIV; and/or other reproductive tract infections. While a few such technologies exist, greater collaboration and resources are needed to accelerate research and development efforts and bring new technologies into widespread use.

Author: Holt BY, Kilbourne-Brook M, Cohen J, Burns M

Publication date: May 2010

Region: Global

Part of the Technology Updates series, this fact sheet describes the SILCS diaphragm project at PATH.

Publication date: May 2012

Region: Global

Part of series: Technology Updates

This document provides an historical profile on the design of PATH's SILCS diaphragm, including clinical evaluations, user acceptability studies, and product features, specifications, and benefits.

Publication date: 2006

Region: Global

This report covers a 2009 consultation in Kampala, Uganda, that was convened by the Global Campaign for Microbicides, the Joint UN Programme on HIV/AIDS, and the US Centers for Disease Control and Prevention. It includes recommendations related to key ethical and practical questions on the design and implementation of clinical trials.

Author: McGrory E, Philpott S, Hankins C, Paxton L, Heise L

Publication date: May 2010

Region: Global

This website about PATH’s Technology Solutions global program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2013

Region: Global

Part of series: PATH's program websites

This fact sheet provides an overview of PATH's work to adapt, design, develop, and advance health technologies to improve global health.

Publication date: December 2011

Region: Global

Part of series: PATH's areas of focus fact sheets

This brief summarizes key findings from a literature review conducted by PATH to identify published and gray literature reporting international experiences with the Uniject™ injection system. The findings shed light on user acceptability and highlight potential cost savings in terms of training time, waste management, and reduction in drug wastage when Uniject is used instead of a standard autodisable syringe. This document synthesizes the experience and evidence on the use of Uniject worldwide with medicines such as the injectable contraceptive Cyclofem®, hepatitis B and tetanus toxoid vaccines, as well as the drug oxytocin, which is used to prevent postpartum hemorrhage.

Publication date: February 2011

Region: Global

Part of the Technology Updates series, this fact sheet describes the Woman's Condom project at PATH.

Publication date: May 2012

Region: Global

Part of series: Technology Updates